These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1769387)

  • 1. Regional central serotonin receptor binding in rats treated chronically with high-dose 5-hydroxy-L-tryptophan.
    Pranzatelli MR
    Exp Brain Res; 1991; 87(2):340-4. PubMed ID: 1769387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High and low affinity 5-HT2 and 5-HT1C binding sites: responses to neonatal 5,7-DHT lesions in rat brain.
    Pranzatelli MR; Gregory CM
    Cytobios; 1993; 75(302-303):197-209. PubMed ID: 8243108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human brainstem serotonin receptors: characterization and implications for subcortical myoclonus.
    Pranzatelli MR; Galvan I; Tailor PT
    Clin Neuropharmacol; 1996 Dec; 19(6):507-14. PubMed ID: 8937789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of chronic treatment with 5-hydroxytryptophan on cortical serotonin receptors in the rat.
    Pranzatelli MR
    Clin Neuropharmacol; 1988 Jun; 11(3):257-62. PubMed ID: 3261199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [3H]1-[2-(4-aminophenyl)ethyl]-4-(3-trifluoromethylphenyl)piperazine: a selective radioligand for 5-HT1A receptors in rat brain.
    Ransom RW; Asarch KB; Shih JC
    J Neurochem; 1986 Jan; 46(1):68-75. PubMed ID: 2933490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 5,7-dihydroxytryptamine on serotonin1 and serotonin2 receptors throughout the rat central nervous system using quantitative autoradiography.
    Fischette CT; Nock B; Renner K
    Brain Res; 1987 Sep; 421(1-2):263-79. PubMed ID: 3690273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional central serotonin-2 receptor binding and phosphoinositide turnover in rats with 5,7-dihydroxytryptamine lesions.
    Butler PD; Pranzatelli MR; Barkai AI
    Brain Res Bull; 1990 Jan; 24(1):125-9. PubMed ID: 2155684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discriminative-stimulus effects of quipazine and l-5-hydroxytryptophan in relation to serotonin binding sites in the pigeon.
    Walker EA; Yamamoto T; Hollingsworth PJ; Smith CB; Woods JH
    J Pharmacol Exp Ther; 1991 Nov; 259(2):772-82. PubMed ID: 1941625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [3H]paroxetine binding and serotonin content of rat and rabbit cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region.
    Dewar KM; Reader TA; Grondin L; Descarries L
    Synapse; 1991 Sep; 9(1):14-26. PubMed ID: 1724575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p,p'-DDT myoclonic/epileptic model: serotonin receptor binding and behavioral studies in the rat.
    Pranzatelli MR; Tailor PT; Pluchino R; Gonzales W; Simmens S
    Neurotoxicology; 1994; 15(2):261-72. PubMed ID: 7991214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin-lesion myoclonic syndromes. I. Neurochemical profile and S-1 receptor binding.
    Pranzatelli MR; Rubin G; Snodgrass SR
    Brain Res; 1986 Jan; 364(1):57-66. PubMed ID: 3484992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Withdrawal from chronic ethanol increases the sensitivity of presynaptic 5-HT(1A) receptors modulating serotonin and dopamine synthesis in rat brain in vivo.
    Esteban S; Moranta D; Sastre-Coll A; Miralles A; García-Sevilla JA
    Neurosci Lett; 2002 Jun; 326(2):121-4. PubMed ID: 12057843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasticity and ontogeny of the central 5-HT transporter: effect of neonatal 5,7-dihydroxytryptamine lesions in the rat.
    Pranzatelli MR; Martens JM
    Brain Res Dev Brain Res; 1992 Dec; 70(2):191-5. PubMed ID: 1477953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.
    Leysen JE; Gommeren W; Van Gompel P; Wynants J; Janssen PF; Laduron PM
    Mol Pharmacol; 1985 Jun; 27(6):600-11. PubMed ID: 2860558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin metabolism in neonatal rat brain during asphyxia and recovery.
    Hedner T; Lundborg P
    Acta Physiol Scand; 1980 Jun; 109(2):163-8. PubMed ID: 6968497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mediation of ACTH and prolactin responses to 5-HTP by 5-HT2 receptors.
    Gartside SE; Cowen PJ
    Eur J Pharmacol; 1990 Apr; 179(1-2):103-9. PubMed ID: 2163847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of two [3H]ketanserin recognition sites in rat striatum.
    Roth BL; McLean S; Zhu XZ; Chuang DM
    J Neurochem; 1987 Dec; 49(6):1833-8. PubMed ID: 2960784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ingestion of a carbohydrate-fat meal on the levels and synthesis of 5-hydroxyindoles in various regions of the rat central nervous system.
    Colmenares JL; Wurtman RJ; Fernstrom JD
    J Neurochem; 1975 Dec; 25(6):825-9. PubMed ID: 1082010
    [No Abstract]   [Full Text] [Related]  

  • 19. Daily LSD administration selectively decreases serotonin2 receptor binding in rat brain.
    Buckholtz NS; Freedman DX; Middaugh LD
    Eur J Pharmacol; 1985 Mar; 109(3):421-5. PubMed ID: 3987809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of 5-HT1, 5-HT2, and 5-HT3 receptors in the mediation of the prolactin response to serotonin and 5-hydroxytryptophan.
    Jørgensen H; Knigge U; Warberg J
    Neuroendocrinology; 1992 Mar; 55(3):336-43. PubMed ID: 1386914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.